Insider holders · CIK 0001390478
SELLAS Life Sciences Group, Inc. · SLS
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Sander Gerber10% Owner | — | 2,036,559 | 2,036,559 | Feb 10, 2017 · 6:16 pm EST | Form 4 |
| Hudson Bay Capital Management LP10% Owner | — | 2,036,559 | 2,036,559 | Feb 10, 2017 · 6:16 pm EST | Form 4 |
| Angelos M. StergiouPresident and CEO | 1,759,183 | — | 1,759,183 | Jun 18, 2026 · 4:30 pm EDT | Form 4 |
| Mark W. SchwartzPresident & CEO | 439,978 | — | 439,978 | Jul 6, 2016 · 5:23 pm EDT | Form 4 |
| Sanford HillsbergDirector | 56,950 | 85,447 | 142,397 | Oct 10, 2017 · 5:56 pm EDT | Form 5 |
| Rudolph NisiDirector | 42,918 | — | 42,918 | Oct 10, 2017 · 6:01 pm EDT | Form 4 |
| Mary Ann GrayDirector | 39,167 | — | 39,167 | Oct 10, 2017 · 5:59 pm EDT | Form 4 |
| William AshtonDirector | 38,154 | — | 38,154 | Oct 10, 2017 · 5:48 pm EDT | Form 4 |
| Stephen S GallikerDirector | 36,039 | — | 36,039 | Oct 10, 2017 · 5:54 pm EDT | Form 4 |
| Irving M. EinhornDirector | 34,690 | — | 34,690 | Oct 10, 2017 · 5:51 pm EDT | Form 4 |
| Richard ChinDirector | 31,339 | — | 31,339 | Oct 10, 2017 · 5:45 pm EDT | Form 4 |
| Ryan DunlapFormer Chief Financial Officer | 18,702 | — | 18,702 | Jun 7, 2016 · 6:36 pm EDT | Form 4 |
| David A ScheinbergDirector | 9,107 | — | 9,107 | Mar 16, 2018 · 4:31 pm EDT | Form 4/A |
| Bijan NejadnikChief Medical Officer | 8,503 | — | 8,503 | Jul 8, 2016 · 2:35 pm EDT | Form 4 |
| Varibobi Financial Holdings Ltd10% Owner | 0 | 3,343 | 3,343 | Sep 26, 2018 · 7:43 pm EDT | Form 4 |
| Equilibria Capital Management Ltd10% Owner | 0 | 3,343 | 3,343 | Sep 26, 2018 · 7:43 pm EDT | Form 4 |
| EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund10% Owner | 0 | 3,343 | 3,343 | Sep 26, 2018 · 7:43 pm EDT | Form 4 |
| Daniel Tafur10% Owner | 0 | 3,343 | 3,343 | Sep 26, 2018 · 7:43 pm EDT | Form 4 |
| EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund10% Owner | 0 | 3,343 | 3,343 | Sep 26, 2018 · 7:43 pm EDT | Form 4 |
| EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`10% Owner | 0 | 3,343 | 3,343 | Sep 26, 2018 · 7:43 pm EDT | Form 4 |
| EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund10% Owner | 0 | 3,343 | 3,343 | Sep 26, 2018 · 7:43 pm EDT | Form 4 |
| Castilian Ltd.10% Owner | 0 | 3,343 | 3,343 | Sep 26, 2018 · 7:43 pm EDT | Form 4 |
| Fabio LopezDirector | 0 | 3,343 | 3,343 | Sep 26, 2018 · 7:43 pm EDT | Form 4 |
| John Thomas BurnsVP, Finance & Corp Controller | 18 | — | 18 | Dec 19, 2018 · 5:11 pm EST | Form 3 |
| Gene MackCFO and Treasurer | 0 | — | 0 | Apr 24, 2018 · 4:52 pm EDT | Form 3 |
| Aleksey N. KrylovInterim CFO | 0 | — | 0 | Dec 29, 2017 · 5:00 pm EST | Form 3 |
| Nicholas J. SarlisChief Medical Officer and SVP | 0 | — | 0 | Dec 29, 2017 · 5:02 pm EST | Form 3 |
| John VarianDirector | 0 | — | 0 | Dec 29, 2017 · 5:07 pm EST | Form 3 |
| Gregory M TorreCRO and SVP | 0 | — | 0 | Dec 29, 2017 · 5:03 pm EST | Form 3 |
| Jane WasmanDirector | 0 | — | 0 | Dec 29, 2017 · 5:08 pm EST | Form 3 |
| Robert L Van NostrandDirector | 0 | — | 0 | Dec 29, 2017 · 5:06 pm EST | Form 3 |
| Barbara A WoodEVP, Gen. Counsel, Corp. Sec. | 0 | — | 0 | Mar 16, 2018 · 4:29 pm EDT | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.